Because non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD is characterized by inflammation and cellular injury, we evaluated the impact of AAA-1 on the expression of the hepatocellular injury marker Cytokeratin-18 (CK-18). The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.